These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 2396256)

  • 21. Corelease of PHI and VIP by vagal stimulation in the dog.
    Yasui A; Naruse S; Yanaihara C; Ozaki T; Hoshino M; Mochizuki T; Daniel EE; Yanaihara N
    Am J Physiol; 1987 Jul; 253(1 Pt 1):G13-9. PubMed ID: 2886054
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vasoactive intestinal peptide in cirrhotic rats: hemodynamic effects and mesenteric arterial receptor characteristics.
    Lee SS; Huang M; Ma Z; Rorstad O
    Hepatology; 1996 May; 23(5):1174-80. PubMed ID: 8621151
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of test meal, intragastric nutrients, and intraduodenal bile on plasma concentrations of immunoreactive somatostatin and vasoactive intestinal peptide in dogs.
    Chayvialle JA; Miyata M; Rayford PL; Thompson JC
    Gastroenterology; 1980 Nov; 79(5 Pt 1):844-52. PubMed ID: 6106620
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Release of vasoactive intestinal polypeptide from the cat small intestine exposed to cholera toxin.
    Cassuto J; Fahrenkrug J; Jodal M; Tuttle R; Lundgren O
    Gut; 1981 Nov; 22(11):958-63. PubMed ID: 7308850
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of vasoactive intestinal polypeptide on antigen-induced bronchoconstriction and thromboxane release in guinea-pig lung.
    Ciabattoni G; Montuschi P; Currò D; Togna G; Preziosi P
    Br J Pharmacol; 1993 May; 109(1):243-50. PubMed ID: 8495242
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vasoactive intestinal polypeptide mediates cholecystokinin-induced relaxation of the sphincter of Oddi.
    Wiley JW; O'Dorisio TM; Owyang C
    J Clin Invest; 1988 Jun; 81(6):1920-4. PubMed ID: 3384954
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Release of vasoactive intestinal peptide by distention of the proximal stomach in dogs.
    Chayvialle JA; Miyata M; Rayford PL; Thompson JC
    Gut; 1980 Sep; 21(9):745-9. PubMed ID: 7429339
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vasoactive intestinal polypeptide and the canine cerebral circulation.
    Wilson DA; O'Neill JT; Said SI; Traystman RJ
    Circ Res; 1981 Jan; 48(1):138-48. PubMed ID: 7438343
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of vasoactive intestinal peptide (VIP) in pathogenesis of ethanol-induced gastric mucosal damage in rats.
    Karmeli F; Eliakim R; Okon E; Rachmilewitz D
    Dig Dis Sci; 1993 Jul; 38(7):1210-9. PubMed ID: 7686841
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased levels of vasoactive intestinal peptide (VIP) and oxytocin during suckling in lactating dogs.
    Eriksson M; Lindén A; Stock S; Uvnäs-Moberg K
    Peptides; 1987; 8(3):411-3. PubMed ID: 3658810
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The release of vasoactive intestinal peptide during altered mid-gut blood flow.
    Bateson PG; Buchanan KD; Stewart DM; Parks TG
    Br J Surg; 1980 Feb; 67(2):131-4. PubMed ID: 7362944
    [TBL] [Abstract][Full Text] [Related]  

  • 32. VPAC2-R mediates the lipolytic effects of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide in primary rat adipocytes.
    Akesson L; Ahrén B; Edgren G; Degerman E
    Endocrinology; 2005 Feb; 146(2):744-50. PubMed ID: 15514088
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Inhalation of a precursor analogue of vasoactive intestinal polypeptide (Leu17 VIP-Gly-Lys) protects ascaris-induced bronchoconstriction in dog].
    Hamada M; Uchida Y; Inoue M; Kameyama M; Nomura A; Ohtsuka M; Itoh O; Tachibana S; Hasegawa S
    Arerugi; 1989 Dec; 38(12):1347-53. PubMed ID: 2634376
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vasoactive intestinal polypeptide-immunoreactive nerves in the kidney.
    Barajas L; Sokolski KN; Lechago J
    Neurosci Lett; 1983 Dec; 43(2-3):263-9. PubMed ID: 6369180
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Release of vasoactive intestinal peptide in the central nervous system in man.
    Ebeid AM; Attia RR; Sundaram P; Fischer JE
    Am J Surg; 1979 Jan; 137(1):123-7. PubMed ID: 31806
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of vasoactive intestinal peptide receptors in canine liver membranes.
    Kiso T; Ito S; Ohta T; Asano T; Nakazato Y
    Biochem Pharmacol; 1994 Jan; 47(2):241-5. PubMed ID: 8304967
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibitory effects of ethanol on the calcium-dependent potentiation of vasoactive intestinal peptide-stimulated cAMP and cGMP accumulation in rat pinealocytes.
    Chik CL; Ho AK
    Biochem Pharmacol; 1991 Sep; 42(8):1601-8. PubMed ID: 1656991
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of vasoactive intestinal polypeptide microinjected into the nucleus tractus solitarius on jejunal glucose absorption in rats.
    Borges EL; Machado AD; Haibara AS; Petroianu A
    Auton Neurosci; 2003 Sep; 107(2):111-3. PubMed ID: 12963422
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lesion patterns of vasoactive intestinal polypeptide-containing neurons in the myenteric plexus induced by clamping or transsection of rat jejunum.
    Trudrung P; Waldner H; Sklarek J; Nitsch C
    Neurosci Lett; 1990 Feb; 109(3):277-81. PubMed ID: 2330130
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distribution of vasoactive intestinal polypeptide (VIP) binding in circular muscle and characterization of VIP binding in canine small intestinal mucosa.
    Mao YK; Barnett W; Coy DH; Tougas G; Daniel EE
    J Pharmacol Exp Ther; 1991 Sep; 258(3):986-91. PubMed ID: 1653848
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.